Co-Authors
This is a "connection" page, showing publications co-authored by Fabio Ciceri and Chiara Oltolini.
Connection Strength
1.689
-
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase. Hemasphere. 2020 Aug; 4(4):e448.
Score: 0.897
-
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020 06; 76:43-49.
Score: 0.442
-
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome. Bone Marrow Transplant. 2021 09; 56(9):2312-2315.
Score: 0.238
-
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021 Mar; 27(3):451-457.
Score: 0.057
-
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020 Jun; 2(6):e325-e331.
Score: 0.055